Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
PMG Research of Wilmington
2455
mi
from 98109
Wilmington, NC
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
PMG Research of Wilmington
2455
mi
from 98109
Wilmington, NC
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Community Research
1970
mi
from 98109
Cincinnati, OH
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Community Research
1970
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Sleep Lab of Northeastern Pennsylvania
2298
mi
from 98109
Clarks Summit, PA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Sleep Lab of Northeastern Pennsylvania
2298
mi
from 98109
Clarks Summit, PA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
SleepMed of SC
2321
mi
from 98109
Columbia, SC
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
SleepMed of SC
2321
mi
from 98109
Columbia, SC
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Coastal Carolina Research Center
2426
mi
from 98109
Mt. Pleasant, SC
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Coastal Carolina Research Center
2426
mi
from 98109
Mt. Pleasant, SC
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
University of Tennesee Health Science Center
1864
mi
from 98109
Memphis, TN
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
University of Tennesee Health Science Center
1864
mi
from 98109
Memphis, TN
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Future Research Trials of Neurology
1770
mi
from 98109
Austin, TX
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Future Research Trials of Neurology
1770
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Clinical Trial Network
1888
mi
from 98109
Houston, TX
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Clinical Trial Network
1888
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Bhupesh Dihenia, M.D., P.A.
1439
mi
from 98109
Lubbock, TX
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Bhupesh Dihenia, M.D., P.A.
1439
mi
from 98109
Lubbock, TX
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Paragon Research Center
1787
mi
from 98109
San Antonio, TX
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Paragon Research Center
1787
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Sleep Medicine Associates
2
mi
from 98109
Seattle, WA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Sleep Medicine Associates
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Targeted Management Intervention for African-American Men With TIA or Stroke
Targeted Management Intervention for African-American Men With TIA or Stroke.
Status: Enrolling
Updated:  1/31/2017
Case Western Reserve Univ
2024
mi
from 98109
Cleveland, OH
Targeted Management Intervention for African-American Men With TIA or Stroke
Targeted Management Intervention for African-American Men With TIA or Stroke.
Status: Enrolling
Updated: 1/31/2017
Case Western Reserve Univ
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics
Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics
Status: Enrolling
Updated:  1/31/2017
MS Center at Evergreen Health
7
mi
from 98109
Kirkland, WA
Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics
Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics
Status: Enrolling
Updated: 1/31/2017
MS Center at Evergreen Health
7
mi
from 98109
Kirkland, WA
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Northwest NeuroSpecialists, PLLC
1213
mi
from 98109
Tucson, AZ
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Northwest NeuroSpecialists, PLLC
1213
mi
from 98109
Tucson, AZ
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
University of Colorado
1026
mi
from 98109
Aurora, CO
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
University of Colorado
1026
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Meridien Research
2527
mi
from 98109
Tampa, FL
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Meridien Research
2527
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Fort Wayne Neurological Center
1874
mi
from 98109
Fort Wayne, IN
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Fort Wayne Neurological Center
1874
mi
from 98109
Fort Wayne, IN
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
MidAmerica Neuroscience Institute
1501
mi
from 98109
Lenexa, KA
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
MidAmerica Neuroscience Institute
1501
mi
from 98109
Lenexa, KA
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
QUEST Research Institute
1917
mi
from 98109
Bingham Farms, MI
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
QUEST Research Institute
1917
mi
from 98109
Bingham Farms, MI
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Great Falls Cllinic
515
mi
from 98109
Great Falls, MT
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Great Falls Cllinic
515
mi
from 98109
Great Falls, MT
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Empire Neurology, PC
2349
mi
from 98109
Latham, NY
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Empire Neurology, PC
2349
mi
from 98109
Latham, NY
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Winthrop University Hospital
2417
mi
from 98109
Mineola, NY
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Winthrop University Hospital
2417
mi
from 98109
Mineola, NY
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Wake Forest University Health Sciences
2279
mi
from 98109
Winston-Salem, NC
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Wake Forest University Health Sciences
2279
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Central Texas Neurology Consultants, P.A.
1758
mi
from 98109
Round Rock, TX
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Central Texas Neurology Consultants, P.A.
1758
mi
from 98109
Round Rock, TX
Click here to add this to my saved trials
Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  1/31/2017
Nationwide Children's Hospital
2009
mi
from 98109
Columbus, OH
Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 1/31/2017
Nationwide Children's Hospital
2009
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Sex and Age Ultrasound Response to Differential Jugular Vein Pressure
Sex and Age Ultrasound Response to Differential Jugular Vein Pressure
Status: Enrolling
Updated:  1/31/2017
Cincinnati Children's Hospital Medical Center
1966
mi
from 98109
Cincinnati, OH
Sex and Age Ultrasound Response to Differential Jugular Vein Pressure
Sex and Age Ultrasound Response to Differential Jugular Vein Pressure
Status: Enrolling
Updated: 1/31/2017
Cincinnati Children's Hospital Medical Center
1966
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Trichuris Suis Ova in Peanut and Tree Nut Allergy
Trichuris Suis Ova Therapy for Mild to Moderate Peanut and Tree Nut Allergy in Adults and Children
Status: Enrolling
Updated:  2/2/2017
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
Trichuris Suis Ova in Peanut and Tree Nut Allergy
Trichuris Suis Ova Therapy for Mild to Moderate Peanut and Tree Nut Allergy in Adults and Children
Status: Enrolling
Updated: 2/2/2017
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Executive Function/Metacognitive Training for At-Risk Preschoolers
Executive Function/Metacognitive Training for At-Risk Preschoolers
Status: Enrolling
Updated:  2/2/2017
Cincinnati Children's Hospital Medical Center
1966
mi
from 98109
Cincinnati, OH
Executive Function/Metacognitive Training for At-Risk Preschoolers
Executive Function/Metacognitive Training for At-Risk Preschoolers
Status: Enrolling
Updated: 2/2/2017
Cincinnati Children's Hospital Medical Center
1966
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
626
mi
from 98109
Sacramento, CA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
626
mi
from 98109
Sacramento, CA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
1065
mi
from 98109
San Diego, CA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
681
mi
from 98109
San Francisco, CA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
681
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
987
mi
from 98109
Santa Ana, CA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
987
mi
from 98109
Santa Ana, CA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
705
mi
from 98109
Stanford, CA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
705
mi
from 98109
Stanford, CA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
1030
mi
from 98109
Centennial, CO
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
1030
mi
from 98109
Centennial, CO
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2432
mi
from 98109
New Haven, CT
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2693
mi
from 98109
Delray Beach, FL
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2693
mi
from 98109
Delray Beach, FL
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2715
mi
from 98109
Oakland Park, FL
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2715
mi
from 98109
Oakland Park, FL
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2544
mi
from 98109
Orlando, FL
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2544
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2181
mi
from 98109
Decatur, GA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2181
mi
from 98109
Decatur, GA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
1733
mi
from 98109
Chicago, IL
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2328
mi
from 98109
Baltimore, MD
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2312
mi
from 98109
Rockville, MD
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2312
mi
from 98109
Rockville, MD
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2475
mi
from 98109
Lexington, MA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2475
mi
from 98109
Lexington, MA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
1393
mi
from 98109
Minneapolis, MN
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2402
mi
from 98109
Bronx, NY
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2402
mi
from 98109
Bronx, NY
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2400
mi
from 98109
New York, NY
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2393
mi
from 98109
Orangeburg, NY
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2393
mi
from 98109
Orangeburg, NY
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
2341
mi
from 98109
Durham, NC
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
1967
mi
from 98109
Cincinnati, OH
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
1967
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials